4.7 Review

Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Applied

The positive correlation of antioxidant activity and prebiotic effect about oat phenolic compounds

Yunzhen Zhang et al.

Summary: This study investigated the correlation between the antioxidant activity and prebiotic effect of oat phenolic compounds. The results showed that phenolic compounds with higher antioxidant capacity can promote the proliferation of beneficial gut microbiota and inhibit the growth of harmful bacteria. This study provides a basis for understanding the relationship between antioxidant stress and gut microbiota regulation.

FOOD CHEMISTRY (2023)

Review Gastroenterology & Hepatology

MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics

Maite Casado-Bedmar et al.

Summary: MicroRNAs (miRNAs) and intestinal microbiota play important roles in the pathophysiology of inflammatory bowel disease (IBD), and their bidirectional communication has therapeutic potential. This review discusses the mechanisms through which miRNAs and intestinal microbiota interact, and the diagnostic power and therapeutic potential resulting from their communication after fecal transplantation, probiotics intake, or anti-miRNAs or miRNA mimics administration.

JOURNAL OF CROHNS & COLITIS (2022)

Article Immunology

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis

Yapeng Yang et al.

Summary: This study investigates the effects of fecal microbiota transplantation (FMT) on colitis symptoms, inflammation, and intestinal barrier in mice models. The study finds that FMT can alleviate the symptoms of colitis, especially when using healthy donor (HD) bacteria. Metagenomic sequencing reveals higher species diversity and abundance of anti-inflammatory bacteria in the HD intervention group. Metabolomics analysis shows that FMT significantly modulates the metabolism of DSS-induced mice. These findings provide new insights into the mechanisms of FMT clinical intervention in inflammatory bowel disease (IBD).

FRONTIERS IN IMMUNOLOGY (2022)

Review Nutrition & Dietetics

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Xue Guo et al.

Summary: Inflammatory bowel disease (IBD) is characterized by relapse and remission, making it challenging to diagnose and assess disease activity. Traditional biomarkers from plasma and stool lack specificity, while changes in gut microbiota are closely associated with IBD etiology and pathogenesis.

FRONTIERS IN NUTRITION (2022)

Review Agriculture, Multidisciplinary

Recent Advances of Stimuli-Responsive Polysaccharide Hydrogels in Delivery Systems: A Review

Yunzhen Zhang et al.

Summary: Hydrogels obtained from natural polymers, with excellent biocompatibility and environmental friendliness, can be used as smart active substance delivery systems. They can respond to external stimuli by changing their volume phase and structure, potentially playing a role in gut microbiota modulation and regulating the gut-brain axis.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2022)

Article Microbiology

Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression

Koen Wortelboer et al.

Summary: The gut microbiota and secreted miRNAs have an interaction, and changes in the microbiota can affect the composition of secreted miRNAs.

MICROBIOLOGICAL RESEARCH (2022)

Review Biochemistry & Molecular Biology

MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer

Letizia Masi et al.

Summary: Inflammatory bowel disease (IBD) is a chronic relapsing autoimmune disease, and miRNAs have the potential to serve as important biomarkers in diagnosis and treatment, as well as for developing a new screening model for colorectal cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

Deficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis

Qingqing Feng et al.

Summary: Deletion of miR-149-3p increases susceptibility to colitis and alters inflammatory cytokine expression, while miR-149-5p and miR-149-3p can suppress colon inflammatory response. Furthermore, deletion of miR-149-3p alters gut microbiota composition.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Review Gastroenterology & Hepatology

Gut microbiota, inflammatory bowel disease and colorectal cancer

Ana Elisa Valencise Quaglio et al.

Summary: Dysbiosis in the gut microbiota is closely associated with various gastrointestinal disorders such as IBS, IBD, and CRC, potentially leading to mucosal barrier disruption, chronic inflammation, and cancer progression. Specific harmful bacteria, like E. coli and ETBF, are linked to an increased risk of developing CRC.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Article Multidisciplinary Sciences

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Jun Zhou et al.

Summary: In this study, genetically engineered probiotics with self-producing functional proteins and biofilm self-coating were developed for the safe and efficient treatment of inflammatory bowel disease (IBD) in mice. The engineered probiotics effectively reduced inflammation, repaired epithelial barriers, and regulated intestinal microbial communities. This study lays a foundation for the development of living therapeutic proteins using probiotics to treat intestinal-related diseases.

NATURE COMMUNICATIONS (2022)

Review Food Science & Technology

MicroRNA sensing and regulating microbiota-host crosstalk via diet motivation

Yaotian Fan et al.

Summary: Diet-derived gut microbiota plays a role in regulating host metabolism and can be used as a biomarker for personalized dietary recommendations. Noncoding RNAs, specifically microRNAs, mediate communication between microbiota and host. MicroRNAs have the potential to be used as circulating biomarkers for personalized dietary strategies in future clinical research implications.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Article Biology

Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences

L. Berbert et al.

Summary: This study investigated the composition of gut microbiota in Brazilian colorectal adenocarcinoma (CRC) patients compared with a control population. The results showed that CRC patients had increased alpha diversity, higher percentage of Prevotella genus, and decreased proportion of Megamonas and Ruminococcus. Faecalibacterium prausnitzii was associated with a better prognosis in early stages of CRC, while Fusobacterium nucleatum was identified as an important marker of colorectal carcinogenesis and tumor aggressiveness.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2022)

Article Gastroenterology & Hepatology

Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study

Adam G. Clooney et al.

Summary: The study found reduced microbiota diversity and increased variability in patients with CD and UC compared to controls. Longitudinal analysis showed decreased temporal microbiota stability in IBD, especially in patients with changes in disease activity. Machine learning was able to separate disease from controls and active from inactive disease.
Review Gastroenterology & Hepatology

Systematic review and meta-analysis of the role ofFaecalibacterium prausnitziialteration in inflammatory bowel disease

Hailan Zhao et al.

Summary: A systematic review and meta-analysis found a negative association between abundance of F. prausnitzii and IBD activity, but a cut-off level of F. prausnitzi for diagnosing and treating IBD has not been determined.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Nutrition & Dietetics

Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs

Francesca Algieri et al.

Summary: The study found that different probiotics have intestinal anti-inflammatory effects, particularly with slight differences in miRNA expression. Additionally, probiotics improved colitis-associated dysbiosis, although the specific bacterial groups affected varied among the probiotics tested.

EUROPEAN JOURNAL OF NUTRITION (2021)

Article Gastroenterology & Hepatology

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Eun Soo Kim et al.

Summary: Pregnancy is associated with reduced inflammatory activity in mothers with IBD, however, babies born to mothers with IBD show subclinical inflammation in early life. The study findings suggest a correlation between maternal FC levels and bacterial abundance.

GASTROENTEROLOGY (2021)

Review Medicine, General & Internal

Gut microbiota and inflammatory bowel disease: The current status and perspectives

Lie Zheng et al.

Summary: Inflammatory bowel disease (IBD) is a chronic immune-mediated disease affecting the gastrointestinal tract. The interaction of environment, microbiome, and immune factors in a genetically susceptible host triggers IBD, leading to an increased interest in microbiome-modulating interventions for treatment. Probiotics, prebiotics, antibiotics, fecal microbiota transplantation, and gene manipulation have shown potential curative effects in treating IBD.

WORLD JOURNAL OF CLINICAL CASES (2021)

Review Cell Biology

MicroRNAs in the interaction between host-bacterial pathogens: A new perspective

Zohreh Riahi Rad et al.

Summary: miRNAs play a critical role in gene expression regulation, affecting biological or pathological processes by targeting specific mRNAs. Bacterial pathogens suppress host miRNA expression for their own benefit, while miRNAs have been extensively studied in the interaction between host and bacterial pathogens.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Gastroenterology & Hepatology

The Burden of Inflammatory Bowel Disease in Europe in 2020

Mirabella Zhao et al.

Summary: New data shows that the incidence and prevalence of inflammatory bowel diseases (IBD) are on the rise worldwide, with approximately 0.2% of the European population currently suffering from IBD. Medical therapy and disease management have significantly advanced, emphasizing close monitoring of disease progression and a treat-to-target approach to prevent early bowel damage and disability. The surgical rate in Europe has decreased over time, with high health economic burden associated with IBD in the region.

JOURNAL OF CROHNS & COLITIS (2021)

Review Biochemistry & Molecular Biology

Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases

Naschla Gasaly et al.

Summary: Butyrate plays a crucial role in maintaining the stability of the digestive ecosystem and reducing inflammation in both health and inflammatory bowel diseases. However, patients with IBD often show lower levels of butyrate-producing bacteria and butyrate content, leading to dysbiosis and impaired barrier function in the gut.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD

Adrian Martyniak et al.

Summary: The increasing incidence of inflammatory bowel diseases necessitates new methods of therapy, with the gut microbiome being studied extensively as a key factor. The composition of intestinal microbiota can be modified by diet and probiotics, and enhanced by the use of paraprobiotics and postbiotics. This study summarizes recent works on various microbiome-altering methods in IBD.

BIOMOLECULES (2021)

Article Gastroenterology & Hepatology

Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p

Yingying Cao et al.

Summary: ETBF promotes CRC cell proliferation by down-regulating miR-149-3p, while exosomal miR-149-3p facilitates Thelper type 17 cell differentiation. The level of miR-149-3p decreases gradually in patients with IBD and CRC, and is negatively correlated with the abundance of ETBF.

GASTROENTEROLOGY (2021)

Review Cell Biology

Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models

Kanika Suri et al.

Summary: Dysregulation of miRNA is associated with various diseases, including cancer, inflammation, cardiovascular disorders, drug resistance, and aging. While commonly studied as biomarkers, ongoing research is exploring their potential therapeutic applications, such as in treating inflammatory bowel disease (IBD).
Article Gastroenterology & Hepatology

Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family

Jingjing Du et al.

Summary: Betaine can prevent obesity and metabolic syndrome by improving gut microbiota dysbiosis. Akkermansia muciniphila plays a crucial role in regulating the effects of betaine and increasing strains that produce short-chain fatty acids (SCFAs).

GUT MICROBES (2021)

Review Oncology

Risk of colorectal cancer in inflammatory bowel diseases

Muhammad Shahid Nadeem et al.

SEMINARS IN CANCER BIOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Evolving therapeutic goals in ulcerative colitis: towards disease clearance

Silvio Danese et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

Michel Adamina et al.

JOURNAL OF CROHNS & COLITIS (2020)

Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

Joana Torres et al.

JOURNAL OF CROHNS & COLITIS (2020)

Article Gastroenterology & Hepatology

Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease

N. S. Ding et al.

JOURNAL OF CROHNS & COLITIS (2020)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Microbiome-Based Biomarkers for IBD

Ashwin N. Ananthakrishnan

INFLAMMATORY BOWEL DISEASES (2020)

Article Gastroenterology & Hepatology

MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease

Friederike Cordes et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)

Article Medicine, General & Internal

Crohn's disease

Giulia Roda et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Medicine, General & Internal

Sulfate-Reducing Bacteria of the Oral Cavity and Their Relation with Periodontitis-Recent Advances

Ivan Kushkevych et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer

Jaslin P. James et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Agriculture, Dairy & Animal Science

Regulation of the intestinal barrier by nutrients: The role of tight junctions

Takuya Suzuki

ANIMAL SCIENCE JOURNAL (2020)

Review Microbiology

Interaction of the microbiota with the human body in health and diseases

Safaa Altves et al.

BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH (2020)

Article Gastroenterology & Hepatology

Microbiome-Based Biomarkers for IBD

Ashwin N. Ananthakrishnan

INFLAMMATORY BOWEL DISEASES (2020)

Article Multidisciplinary Sciences

The gut microbiota heterogeneity and assembly changes associated with the IBD

Yang Sun et al.

SCIENTIFIC REPORTS (2019)

Review Genetics & Heredity

Host-MicroRNA-Microbiota Interactions in Colorectal Cancer

Ce Yuan et al.

Review Biotechnology & Applied Microbiology

Akkermansia muciniphila is a promising probiotic

Ting Zhang et al.

MICROBIAL BIOTECHNOLOGY (2019)

Review Chemistry, Medicinal

MicroRNAs, intestinal inflammatory and tumor

Yuan Feng et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Review Gastroenterology & Hepatology

Gut microbiota, dysbiosis and colon lavage

Lorenzo Drago et al.

DIGESTIVE AND LIVER DISEASE (2019)

Article Multidisciplinary Sciences

Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide

Matthew T. Henke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Nutrition & Dietetics

Gut Microbiome: Profound Implications for Diet and Disease

Ronald D. Hills et al.

NUTRIENTS (2019)

Article Immunology

Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice

Rui Zhai et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Review Cell Biology

Inflammatory Bowel Disease: A Stressed Gut/Feeling

Yvonne Oligschlaeger et al.

Review Medicine, Research & Experimental

Diet as Regulator of Gut Microbiota and its Role in Health and Disease

Monica Sanchez-Tapia et al.

ARCHIVES OF MEDICAL RESEARCH (2019)

Article Gastroenterology & Hepatology

Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease

Yi Jie Weng et al.

JOURNAL OF DIGESTIVE DISEASES (2019)

Review Gastroenterology & Hepatology

Review article: fungal alterations in inflammatory bowel diseases

Siu Lam et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Multidisciplinary Sciences

Remission in Crohn's disease is accompanied by alterations in the gut microbiota and mucins production

Daniela Oliveira Magro et al.

SCIENTIFIC REPORTS (2019)

Review Biochemistry & Molecular Biology

An insight into gut microbiota and its functionalities

Atanu Adak et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Review Food Science & Technology

A next generation probiotic, Akkermansia muciniphila

Qixiao Zhai et al.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)

Review Biochemistry & Molecular Biology

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature

Ivana Milosevic et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Cell Biology

MiRNAs and inflammatory bowel disease: An interesting new story

Soheila Moein et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Medicine, Research & Experimental

Host-derived fecal microRNAs can indicate gut microbiota healthiness and ability to induce inflammation

Emilie Viennois et al.

THERANOSTICS (2019)

Article Gastroenterology & Hepatology

Adherent-invasive Escherichia coli in inflammatory bowel disease

Carolina Palmela et al.

Article Biochemistry & Molecular Biology

Faecal microRNA as a biomarker of the activity and prognosis of inflammatory bowel diseases

Yahong Ji et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Gastroenterology & Hepatology

Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases

Katharina Schoenauen et al.

INFLAMMATORY BOWEL DISEASES (2018)

Article Gastroenterology & Hepatology

Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis

Daniel G. W. Johnston et al.

JOURNAL OF CROHNS & COLITIS (2018)

Review Gastroenterology & Hepatology

The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease

Shiyuan Wang et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)

Review Microbiology

Gut Microbiota: An Integral Moderator in Health and Disease

Qingqing Feng et al.

FRONTIERS IN MICROBIOLOGY (2018)

Article Multidisciplinary Sciences

Environment dominates over host genetics in shaping human gut microbiota

Daphna Rothschild et al.

NATURE (2018)

Review Biochemistry & Molecular Biology

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis

Paola Dongiovanni et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Medicine, General & Internal

The clinical effects of probiotics for inflammatory bowel disease A meta-analysis

Kai Jia et al.

MEDICINE (2018)

Review Gastroenterology & Hepatology

Gut microbiota in the pathogenesis of inflammatory bowel disease

Atsushi Nishida et al.

CLINICAL JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Fungal microbiota dysbiosis in IBD

Harry Sokol et al.

Article Gastroenterology & Hepatology

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

Marcus Harbord et al.

JOURNAL OF CROHNS & COLITIS (2017)

Review Medicine, General & Internal

Crohn's disease

Joana Torres et al.

LANCET (2017)

Article Genetics & Heredity

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

Andrew Brantley Hall et al.

GENOME MEDICINE (2017)

Review Microbiology

MicroRNAs-Based Inter-Domain Communication between the Host and Members of the Gut Microbiome

Maggie R. Williams et al.

FRONTIERS IN MICROBIOLOGY (2017)

Review Gastroenterology & Hepatology

Novel insights into microbiome in colitis and colorectal cancer

Ye Yang et al.

CURRENT OPINION IN GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

The Role of the Gut Microbiota in Bile Acid Metabolism

Oscar Ramirez-Perez et al.

ANNALS OF HEPATOLOGY (2017)

Article Biochemistry & Molecular Biology

MicroRNAs at the epicenter of intestinal homeostasis

Antoaneta Belcheva

BIOESSAYS (2017)

Article Microbiology

The Host Shapes the Gut Microbiota via Fecal MicroRNA

Shirong Liu et al.

CELL HOST & MICROBE (2016)

Article Medicine, General & Internal

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease

Huiling Wang et al.

MEDICINE (2016)

Review Medicine, General & Internal

The Human Intestinal Microbiome in Health and Disease

Susan V. Lynch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Gastroenterology & Hepatology

The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models

Ioana Miruna Balmus et al.

SAUDI JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease

Christopher R. Heier et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

The microbiota in inflammatory bowel disease

Donal Sheehan et al.

JOURNAL OF GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

The emerging role of miRNAs in inflammatory bowel disease: a review

Christopher G. Chapman et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)

Article Biochemistry & Molecular Biology

MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis

Surajit Pathak et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2015)

Article Biochemistry & Molecular Biology

An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration

Raghu R. Chivukula et al.

Article Gastroenterology & Hepatology

Dysbiosis in the inflamed intestine Chance favors the prepared microbe

Sebastian E. Winter et al.

GUT MICROBES (2014)

Review Immunology

Intestinal epithelial cells: regulators of barrier function and immune homeostasis

Lance W. Peterson et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Review Microbiology

'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution

Baerbel Stecher et al.

NATURE REVIEWS MICROBIOLOGY (2013)

Article Multidisciplinary Sciences

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

Patrick M. Smith et al.

SCIENCE (2013)

Review Immunology

The Microbiome in Infectious Disease and Inflammation

Kenya Honda et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Article Gastroenterology & Hepatology

Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates

Eric R. Fedyk et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Medicine, General & Internal

Ulcerative colitis

Ingrid Ordas et al.

LANCET (2012)

Editorial Material Gastroenterology & Hepatology

MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics

Mehmet Coskun et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease

Paraskevi Archanioti et al.

JOURNAL OF CROHNS & COLITIS (2011)

Article Multidisciplinary Sciences

Microbiota Modulate Host Gene Expression via MicroRNAs

Guillaume Dalmasso et al.

PLOS ONE (2011)

Article Gastroenterology & Hepatology

Identification of MicroRNAs Associated with Ileal and Colonic Crohn's Disease

Feng Wu et al.

INFLAMMATORY BOWEL DISEASES (2010)

Article Multidisciplinary Sciences

A human gut microbial gene catalogue established by metagenomic sequencing

Junjie Qin et al.

NATURE (2010)

Article Multidisciplinary Sciences

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

Tamia A. Harris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemical Research Methods

Rapid and noninvasive metabonomic characterization of inflammatory bowel disease

Julian R. Marchesi et al.

JOURNAL OF PROTEOME RESEARCH (2007)

Article Multidisciplinary Sciences

Diversity of the human intestinal microbial flora

PB Eckburg et al.

SCIENCE (2005)